| SNP ID |
Visualize variation |
Clinical significance |
Consequence |
| rs35269563 |
A>G |
Conflicting-interpretations-of-pathogenicity |
Missense variant, coding sequence variant |
| rs142069429 |
C>T |
Conflicting-interpretations-of-pathogenicity, uncertain-significance |
Genic downstream transcript variant, coding sequence variant, missense variant |
| rs387907024 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
| rs387907025 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
| rs542547163 |
G>A |
Pathogenic |
Genic downstream transcript variant, intron variant |
| rs746709222 |
C>T |
Pathogenic |
Stop gained, coding sequence variant |
| rs765471424 |
T>C |
Pathogenic |
Splice donor variant |
| rs766413410 |
C>A,G,T |
Pathogenic |
Intron variant |
| rs771945804 |
C>A,G,T |
Pathogenic |
Coding sequence variant, synonymous variant, stop gained |
| rs777096695 |
G>A,T |
Pathogenic, likely-pathogenic |
Splice donor variant |
| rs863223895 |
G>A,C |
Pathogenic |
Initiator codon variant, missense variant |
| rs868431923 |
G>A,T |
Pathogenic |
Splice donor variant |
| rs886041491 |
A>G,T |
Pathogenic |
Genic downstream transcript variant, splice acceptor variant |
| rs886041835 |
G>T |
Pathogenic |
Splice acceptor variant |
| rs1554399572 |
T>C |
Pathogenic |
Splice donor variant |
| rs1554401640 |
A>G |
Pathogenic |
Splice acceptor variant |
| rs1554401641 |
T>G |
Pathogenic |
Coding sequence variant, stop gained |
| rs1587053244 |
G>A |
Likely-pathogenic |
Stop gained, coding sequence variant |
| rs1587162871 |
T>G |
Likely-pathogenic |
Splice donor variant |
|
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q53H12 |
| Protein name |
Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase) |
| Protein function |
Lipid kinase that can phosphorylate both monoacylglycerol and diacylglycerol to form lysophosphatidic acid (LPA) and phosphatidic acid (PA), respectively (PubMed:15939762). Does not phosphorylate sphingosine (PubMed:15939762). Phosphorylates cer |
| PDB |
7CGP
|
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF00781 |
DAGK_cat |
62 → 195 |
Diacylglycerol kinase catalytic domain |
Family |
|
| Tissue specificity |
TISSUE SPECIFICITY: Highly expressed in muscle, heart, kidney and brain. {ECO:0000269|PubMed:15939762}. |
| Sequence |
|
| Sequence length |
422 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| AGK-related disorder |
Pathogenic |
rs2485391716, rs765471424 |
RCV003492749 RCV004541541 |
| Autosomal recessive AGK-related phenotype |
Likely pathogenic; Pathogenic |
rs766413410 |
RCV000984913 |
| Cataract 38 |
Pathogenic; Likely pathogenic |
rs1259937492, rs2116998520, rs1199705359, rs773677513, rs746709222, rs766413410, rs2485410329, rs2485501462, rs2485465829, rs2485410335, rs886041491, rs2485379262, rs139967538, rs2485379466, rs2485387302, rs387907025, rs765471424, rs777096695, rs1554405928, rs771945804, rs1228071168, rs1797560612 View all (7 more) |
RCV001382409 RCV001933190 RCV002044696 RCV003091648 RCV001852539 RCV000024610 RCV002847437 RCV002862667 RCV003059184 RCV003048475 RCV003765578 RCV003779486 RCV003785050 RCV003804110 RCV003817962 RCV005222702 RCV002527087 RCV005208714 RCV000696618 RCV003769020 RCV005213456 RCV005213511 |
| Sengers syndrome |
Pathogenic; Likely pathogenic |
rs778049466, rs1259937492, rs2116998520, rs1199705359, rs2485391716, rs773677513, rs746709222, rs766413410, rs2485410329, rs2485501462, rs863223895, rs2485465829, rs2485410335, rs886041491, rs368565785, rs2485379262, rs139967538, rs2485379466, rs2485387302, rs1554399572, rs1554405935, rs868431923, rs387907024, rs1554401641, rs387907025, rs771945804, rs542547163, rs765471424, rs777096695, rs1554401640, rs1554405947, rs1554405928, rs1587181981, rs1587053244, rs1587162871, rs1228071168, rs771375243, rs1797560612 View all (23 more) |
RCV001336431 RCV001382409 RCV001933190 RCV002044696 RCV002283348 RCV003091648 RCV000191059 RCV000191058 RCV002847437 RCV002862667 RCV000023811 RCV003059184 RCV003048475 RCV003765578 RCV003330156 RCV003779486 RCV003785050 RCV003804110 RCV003817962 RCV000023808 RCV000023809 RCV000023810 RCV000023812 RCV000023813 RCV000023814 RCV000023815 RCV000023816 RCV002527087 RCV000538499 RCV000578375 RCV000578454 RCV000696618 RCV000787336 RCV000985092 RCV000991387 RCV002471037 RCV001095709 RCV001268954 RCV001268953 |
| Thyroid cancer, nonmedullary, 1 |
Pathogenic |
rs2485379466 |
RCV005934933 |
| Trichohepatoenteric syndrome 1 |
Pathogenic |
rs746709222 |
RCV000679854 |
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Developmental cataract |
Uncertain significance; Likely benign; Conflicting classifications of pathogenicity |
rs886062017, rs560194759, rs886062029, rs886062018, rs143849281, rs148553992, rs552726046, rs886062021, rs142235678, rs886062023, rs886062028, rs886062030 |
RCV000364867 RCV000376499 RCV000349405 RCV000266812 RCV000376564 RCV000312506 RCV000324959 RCV000404456 RCV000273641 RCV000272328 RCV000268303 RCV000402583 |
| Familial cancer of breast |
Likely benign |
rs371220594 |
RCV005928694 |
| Gastric cancer |
Uncertain significance |
rs1410173365 |
RCV005926791 |
| Mitochondrial disease |
Conflicting classifications of pathogenicity |
rs367844999, rs561898521 |
RCV005359887 RCV005367734 |
| Ovarian serous cystadenocarcinoma |
Conflicting classifications of pathogenicity |
rs199977261, rs200973491 |
RCV005893485 RCV005899181 |
|
| Disease Name |
Relationship Type |
References |
| Acidosis Lactic |
Associate |
28712726, 33476211, 36253788 |
| Adenocarcinoma of Lung |
Associate |
31747139 |
| Carcinoma Ovarian Epithelial |
Stimulate |
35934718 |
| Carcinoma Renal Cell |
Associate |
31900208, 37009826 |
| Cardiomyopathies |
Associate |
22284826, 34948281 |
| Cardiomyopathy Hypertrophic |
Associate |
28712724, 28712726, 33120694, 33476211 |
| Cataract |
Associate |
22284826, 28712724, 28712726, 33120694, 33476211, 34948281, 36253788 |
| Cataract and cardiomyopathy |
Associate |
22284826, 28712724, 28712726, 33120694, 33476211, 34948281, 36253788, 39824030 |
| Death |
Associate |
34948281 |
| Dilatation Pathologic |
Associate |
34948281 |
| Epiretinal Membrane |
Associate |
22103573 |
| Fatigue |
Associate |
39824030 |
| Fibrosarcoma |
Associate |
31747139 |
| Lymphatic Metastasis |
Stimulate |
26443540 |
| Melanoma |
Associate |
35871080 |
| Muscular Diseases |
Associate |
28712724, 28712726, 33476211 |
| Myopia |
Associate |
29346494 |
| Nasopharyngeal Carcinoma |
Stimulate |
26443540 |
| Neoplasm Metastasis |
Associate |
30657560, 31900208 |
| Neoplasms |
Associate |
19549252, 26443540, 26662108, 28712724, 31747139, 31900208 |
| Neoplasms Glandular and Epithelial |
Associate |
19549252 |
| Neoplasms Squamous Cell |
Associate |
26662108 |
| Ovarian Neoplasms |
Associate |
35934718 |
| Prostatic Neoplasms |
Associate |
19549252 |
| Squamous Cell Carcinoma of Head and Neck |
Associate |
30657560 |
| Thyroid Cancer Papillary |
Associate |
27037835 |
| Thyroid Neoplasms |
Associate |
27037835, 32737449 |
| Uterine Cervical Neoplasms |
Stimulate |
26662108 |
| Vitreoretinopathy Proliferative |
Associate |
22103573 |
|